ARCHIVES

Radium 223 Dichloride Reduces Death Risk By 30 Percent in Castration-Resistant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Senate Appropriators Reject President’s $228 Million Increase For Cancer Research; House and Senate Report Language

September 18, 2009

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

Study Uncovers New Mechanism In Class of Chemotherapy Drugs

November 30, 2012

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977